These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9623579)

  • 1. Preservation of renal function: the spectrum of effects by calcium channel blockers.
    Deray G
    Nephrol Dial Transplant; 1998 May; 13(5):1315-6. PubMed ID: 9623579
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium channel blockers and renal dysfunction in arterial hypertension.
    Díez J
    Nephrol Dial Transplant; 1995; 10 Suppl 6():22-6. PubMed ID: 8524489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers: effects on progressive renal disease.
    Zucchelli P; Zuccalà A; Gaggi R
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):94-7. PubMed ID: 2024684
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists: hypotensive and humoral actions in different forms of hypertension.
    Heidland A; Riegel W; Hörl W; Weipert J; Geiger H; Heidbreder E
    Contrib Nephrol; 1985; 49():201-18. PubMed ID: 3830568
    [No Abstract]   [Full Text] [Related]  

  • 6. [The comparative characteristics of the renal protective properties of angiotensin-converting enzyme inhibitors and calcium channel blockers].
    Kolesnyk MO; Lapchyns'ka II; Hromova AIe; Kassyr KhI
    Lik Sprava; 2000; (3-4):11-5. PubMed ID: 10921249
    [No Abstract]   [Full Text] [Related]  

  • 7. Can calcium channel blockers preserve renal function better than diuretics during antihypertensive treatment?
    Fukuda M; Kimura G
    Arch Intern Med; 2005 Jun; 165(11):1312; author reply 1312-3. PubMed ID: 15956015
    [No Abstract]   [Full Text] [Related]  

  • 8. Dihydropyridine calcium channel blockers and renal disease.
    Robles NR; Fici F; Grassi G
    Hypertens Res; 2017 Jan; 40(1):21-28. PubMed ID: 27412800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetes mellitus and hypertension: calcium antagonists or ACE inhibitors?].
    Jungmann E
    Dtsch Med Wochenschr; 1991 May; 116(22):859-62. PubMed ID: 2036945
    [No Abstract]   [Full Text] [Related]  

  • 10. [Renal effects of calcium antagonists].
    Leonetti G
    Cardiologia; 1984; 29(9-10):439-41. PubMed ID: 6543509
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.
    Abe M; Okada K; Maruyama N; Matsumoto S; Maruyama T; Fujita T; Matsumoto K; Soma M
    Expert Opin Investig Drugs; 2010 Sep; 19(9):1027-37. PubMed ID: 20649501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blockers and nephroprotection.
    Ungar A; Di Serio C; Lambertucci L; Monami M; Masotti G
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):31-9. PubMed ID: 16640171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do calcium antagonists protect the human hypertensive kidney?
    Bauer JH; Reams GP
    Am J Hypertens; 1989 Jun; 2(6 Pt 2):173S-178S. PubMed ID: 2665788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic hypertension and antihypertensive agents.
    Maschio G; Marcantoni C; Bernich P
    J Nephrol; 1999; 12 Suppl 2():S100-4. PubMed ID: 10688408
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of combination therapy with angiotensin II type I receptor blockers and calcium channel blockers on renal function in hypertensive patients/a retrospective, "real-world" comparative study.
    Yamada H; Suga N; Maeda K; Kimura Y; Miura N; Futenma A; Imai H
    Arzneimittelforschung; 2010; 60(2):64-70. PubMed ID: 20329653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of calcium antagonists.
    Rodicio JL; Campo C; Ruilope LM
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():17-22. PubMed ID: 8643202
    [No Abstract]   [Full Text] [Related]  

  • 18. Introduction: the role of calcium antagonists.
    van Zwieten PA
    J Hypertens Suppl; 1998 Oct; 16(6):S1-2. PubMed ID: 9856376
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium channel blockers in hypertension.
    Maharaj B
    Int J Cardiol; 1989 Oct; 25(1):1-6. PubMed ID: 2529222
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium antagonism with felodipine in essential hypertension. Effects on cardiovascular and renal function, the sympathetic and the renin-angiotensin-aldosterone systems, glucose tolerance and glucoregulatory hormones.
    Katzman PL
    Acta Med Scand Suppl; 1987; 720():1-62. PubMed ID: 3328471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.